

Sanofi is recalling Allegra and Combiflam suspension drugs in India due to microbiological contamination, affecting children. The recall is a precautionary measure following previous recalls of other products from the same manufacturing site. The company has halted sales of affected batches and is working on resuming supplies while prioritizing patient safety.


Sanofi is recalling Allegra and Combiflam suspension drugs in India due to microbiological contamination, affecting children. The recall is a precautionary measure following previous recalls of other products from the same manufacturing site. The company has halted sales of affected batches and is working on resuming supplies while prioritizing patient safety.
•The recall is a precautionary measure following previous recalls of other products from the same manufacturing site.
•Sales of affected batches have been halted, with a focus on patient safety and ensuring quality products in the market.
Need any assistance with your queries?
Our AI chatbot support is always available to provide answers to any questions but to begin with, here are some of our most asked questions
Why is Sanofi recalling Allegra and Combiflam suspension drugs in India?
What precautionary measures has Sanofi taken regarding the recall of the drugs?
How is Sanofi ensuring the quality of its products during the recall process?







